- Home
- NCNO vs XENE Comparison
NCNO vs XENE Comparison
Compare NCNO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNO
- XENE
- Stock Information
- Founded
- NCNO 2011
- XENE 1996
- Country
- NCNO United States
- XENE Canada
- Employees
- NCNO N/A
- XENE N/A
- Industry
- NCNO Computer Software: Prepackaged Software
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NCNO Technology
- XENE Health Care
- Exchange
- NCNO Nasdaq
- XENE Nasdaq
- Market Cap
- NCNO 3.1B
- XENE 2.9B
- IPO Year
- NCNO 2020
- XENE 2014
- Fundamental
- Price
- NCNO $24.31
- XENE $41.90
- Analyst Decision
- NCNO Buy
- XENE Strong Buy
- Analyst Count
- NCNO 17
- XENE 11
- Target Price
- NCNO $34.40
- XENE $52.73
- AVG Volume (30 Days)
- NCNO 2.0M
- XENE 775.1K
- Earning Date
- NCNO 12-03-2025
- XENE 11-11-2025
- Dividend Yield
- NCNO N/A
- XENE N/A
- EPS Growth
- NCNO N/A
- XENE N/A
- EPS
- NCNO N/A
- XENE N/A
- Revenue
- NCNO $573,119,000.00
- XENE $7,500,000.00
- Revenue This Year
- NCNO $10.88
- XENE N/A
- Revenue Next Year
- NCNO $8.58
- XENE $207.88
- P/E Ratio
- NCNO N/A
- XENE N/A
- Revenue Growth
- NCNO 13.24
- XENE N/A
- 52 Week Low
- NCNO $18.75
- XENE $26.74
- 52 Week High
- NCNO $43.20
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- NCNO 28.63
- XENE 66.02
- Support Level
- NCNO $25.31
- XENE $39.35
- Resistance Level
- NCNO $26.53
- XENE $41.66
- Average True Range (ATR)
- NCNO 0.88
- XENE 1.54
- MACD
- NCNO -0.26
- XENE 0.17
- Stochastic Oscillator
- NCNO 10.88
- XENE 95.28
About NCNO nCino Inc.
Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.